The company aims to advise life science industry companies, biotech companies, pharmaceutical companies and medical device companies on matters such as corporate development, management, research and development, preclinical product development, safety assessments and other business activities. Furthermore, the company aims to trade in cryptocurrencies, stocks, ETFs and real estate. The company may establish branches in Switzerland and abroad, participate in other companies in Switzerland and abroad, acquire similar or related companies or merge with them, and enter into all transactions and conclude contracts that are suitable to promote the purpose of the company or are directly or indirectly related to it. It may acquire, manage, encumber and sell properties, real estate, intellectual property rights and licenses of all kinds.